Zoster Vaccine (Herpes Zoster / Shingles Vaccine): Shingrix Complete Clinical Guide

Uniqcret doctor knowledgesINMEDINMED ID
On this page

💉 Zoster Vaccine (Herpes Zoster / Shingles Vaccine)

Overview

Herpes zoster (shingles) is caused by reactivation of varicella-zoster virus (VZV), leading to a painful vesicular rash and potential complications such as postherpetic neuralgia (PHN). Vaccination is the most effective method to prevent shingles and its complications.

⭐ Preferred Vaccine: Recombinant Zoster Vaccine (RZV)

Brand name: Shingrix®

Shingrix is currently the vaccine of choice worldwide for shingles prevention.

🧪 Vaccine Type & Composition

  • Type: Recombinant, adjuvanted vaccine (non-live)
  • Antigen: VZV glycoprotein E
  • Adjuvant: AS01B (enhances immune response)
  • Strength: 50 micrograms (mcg) per dose

✅ Because it is non-live, it is safe for immunocompromised patients.

💉 Dose & Administration

  • Dose: 0.5 mL
  • Route: Intramuscular (IM)
  • Site: Deltoid muscle

📆 Schedule

  • Total: 2 doses
    • Dose 1: Day 0
    • Dose 2: 2–6 months after dose 1
    • (Immunocompromised patients: dose 2 may be given at 1–2 months)

📌 If delayed:

  • Do NOT restart the series — simply give the missing dose.

👥 Indications

Shingrix is recommended for:

  • All adults ≥50 years
  • Adults ≥19 years who are immunocompromised
  • Individuals with:
    • Prior shingles episode
    • Prior receipt of live zoster vaccine (Zostavax)

⏳ Duration of Protection

  • Provides strong protection for at least 10 years
  • Vaccine efficacy:
    • 90% in preventing shingles
    • 85% in preventing postherpetic neuralgia
  • No booster dose currently recommended

⚠️ Contraindications & Precautions

Contraindications

  • Severe allergic reaction to a previous dose or vaccine component

Precautions

  • Moderate or severe acute illness (delay vaccination)
  • Pregnancy (limited data; generally deferred)

🤒 Common Adverse Effects

Very common but self-limited:

  • Injection site pain, redness, swelling
  • Fatigue
  • Fever
    • 🌡️ Fever after Shingrix® (Zoster Vaccine) — How common?

      • About 20–30% of people develop fever (≥38°C)
      • Most fevers are mild to moderate
      • High fever (>39°C) is rare (≈ 1% or less)
    • ⏱️ Timing

      • Usually occurs within 1–3 days after vaccination
      • Resolves on its own within 2–3 days
  • Myalgia, headache

🧠 Clinical tip: Reactogenicity is common — warn patients in advance.

❌ Older Vaccine (Exam Knowledge)

Live Zoster Vaccine (ZVL – Zostavax®)

  • Live attenuated
  • Single SC dose
  • Contraindicated in immunocompromised
  • No longer recommended / discontinued in many countries

📌 High-Yield Exam Summary

  • Shingrix = recombinant, non-live
  • Dose: 0.5 mL IM
  • Schedule: 2 doses (0, 2–6 months)
  • Protection: ≥10 years
  • No booster needed
  • Safe in immunocompromised

🧠 One-line Memory Aid

Zoster vaccine = Shingrix = 2-dose IM recombinant vaccine with long-term protection.

0
Message for International and Thai ReadersUnderstanding My Medical Context in ThailandRead more →Message for International and Thai ReadersUnderstanding My Broader Content Beyond MedicineRead more →

Comments

No comments yet. Be the first to share your thoughts.

Sign in to comment